/ ANRO
/ Market Analysis
Why Did ANRO Stock Jump in Premarket: FDA Fast Track Schizophrenia Drug
ANRO stock rose over 6% in premarket after the FDA granted Fast Track status to ALTO-101, its schizophrenia drug candidate.
October 03, 2025